financetom
Business
financetom
/
Business
/
Why Kids Online Clothing Firm Kidpik Shares Are Jumping Premarket Tuesday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Kids Online Clothing Firm Kidpik Shares Are Jumping Premarket Tuesday
Apr 2, 2024 4:47 AM

Kidpik Corp. ( PIK ) shares rocketed premarket Tuesday after it disclosed a definitive merger agreement with Nina Footwear Corp. in an all-stock transaction.

As per the terms, Nina Footwear stockholders will be issued Kidpik’s common shares, such that upon closing, its stockholders will own 80% of Kidpik’s outstanding common shares.

Notably, Kidpik ( PIK ) is controlled by Mr. Ezra Dabah, the Chief Executive Officer, Chairman, and majority shareholder (67% beneficial owner) of Kidpik ( PIK ), who is also the Chief Executive Officer of Nina Footwear. 

Dabah said, “Our transaction is expected to increase Kidpik’s revenue, cashflow and prospects, while also strengthening Kidpik’s balance sheet and significantly increasing stockholder value.”  

“As a team we will refocus our attention on growing Nina through brand and category extensions, international expansion, the resurrection of the Delman shoe brand, and mining our extensive Nina Footwear archive for additional growth, which we believe presents great value. I believe the retention of the net operating loss carryforwards is of tremendous value to our shareholders in entering into the merger,” 

According to the terms of the merger agreement, Kidpik ( PIK ) will acquire Nina Footwear through a reverse subsidiary merger that is intended to be a tax-free reorganization. 

After the merger-closure, the combined company will be renamed “Nina Holding Corp.” and its symbol will change to “NINA”. 

The transaction is projected to close in the third quarter of 2024, subject to customary closing conditions. 

As of September 30, 2023, the company had cash of $0.06 million.

Price Action: PIK shares are up 66.7% at $7.25 premarket on the last check Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Are TotalEnergies Shares Falling Tuesday?
Why Are TotalEnergies Shares Falling Tuesday?
Aug 6, 2024
TotalEnergies SE ( TTE ) shares are trading lower today after the company agreed to sell its 50% stake in Total PARCO Pakistan Limited (TPPL) to Gunvor Group for an undisclosed amount. This move aligns with TotalEnergies’ strategy to concentrate on core markets with growth potential and transition opportunities. TPPL is a joint venture equally owned by TotalEnergies Marketing and Services...
Delek Logistics Partners' Shares Inactive After Reporting Q2 Net Income, Net Revenue Increase
Delek Logistics Partners' Shares Inactive After Reporting Q2 Net Income, Net Revenue Increase
Aug 6, 2024
09:37 AM EDT, 08/06/2024 (MT Newswires) -- Delek Logistics Partners' ( DKL ) shares were inactive in early trading after reporting Q2 net income Tuesday of $0.87 per diluted limited partner unit, up from $0.73 a year earlier. Analysts polled by Capital IQ expected $0.82. Net revenue for the quarter ended June 30 was $264.6 million, compared with $246.9 million...
NCR Voyix Reports Lower-Than-Expected Q2 Non-GAAP Earnings, Revenue; 2024 Revenue Outlook Cut
NCR Voyix Reports Lower-Than-Expected Q2 Non-GAAP Earnings, Revenue; 2024 Revenue Outlook Cut
Aug 6, 2024
09:33 AM EDT, 08/06/2024 (MT Newswires) -- NCR Voyix ( VYX ) reported Q2 non-GAAP earnings Tuesday of $0.09 per diluted share. Analysts polled by Capital IQ expected $0.17. NCR Voyix ( VYX ) was formed after the company's ATM-focused business was spun off as NCR Atleos in October last year. Revenue for the quarter ended June 30 was $876...
Harmony Biosciences' Q2 Adjusted EPS, Revenue Rise; Shares Gain
Harmony Biosciences' Q2 Adjusted EPS, Revenue Rise; Shares Gain
Aug 6, 2024
09:34 AM EDT, 08/06/2024 (MT Newswires) -- Harmony Biosciences ( HRMY ) reported Q2 adjusted earnings Tuesday of $1.05 per diluted share, compared with $0.76 a year earlier. Two analysts surveyed by Capital IQ expected $0.12 Net product revenue for the quarter ended June 30 was $172.8 million, compared with $134.2 million a year earlier. Analysts surveyed by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved